These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 14993339)

  • 1. Academic entrepreneur--an oxymoron?
    Gee K
    Mol Interv; 2001 Oct; 1(4):186-8. PubMed ID: 14993339
    [No Abstract]   [Full Text] [Related]  

  • 2. Realizing potential: the state of Asian bioentrepreneurship.
    Tang CM; Mahmud MA; Foo FK; Chu SY; Chiu RI; Tanticharoen M; Zhang L; Chang TW
    Nat Biotechnol; 2003 Jul; 21 Suppl():BE15-22. PubMed ID: 12874972
    [No Abstract]   [Full Text] [Related]  

  • 3. Writing your business plan.
    Cohen L
    Nat Biotechnol; 2002 Jul; 20 Suppl():BE33-5. PubMed ID: 12089584
    [No Abstract]   [Full Text] [Related]  

  • 4. The nuts and bolts of startups.
    Kiplinger J; Last K
    Nat Biotechnol; 2002 Jul; 20 Suppl():BE29-31. PubMed ID: 12089583
    [No Abstract]   [Full Text] [Related]  

  • 5. Strategic rethink for German biotechnology.
    Fernandes M; Miska D
    Nat Biotechnol; 2002 Oct; 20(10):970-1. PubMed ID: 12355106
    [No Abstract]   [Full Text] [Related]  

  • 6. When times get tough.
    Jong S
    Nat Biotechnol; 2009 Mar; 27(3):226-8. PubMed ID: 19274868
    [No Abstract]   [Full Text] [Related]  

  • 7. Marketing biotechnology with a Gallic flair.
    Jouanneau AC
    Nat Biotechnol; 2003 Jul; 21 Suppl():BE36-7. PubMed ID: 12874977
    [No Abstract]   [Full Text] [Related]  

  • 8. Getting reimbursement for your product in the United States.
    Gold M
    Nat Biotechnol; 2003 Jul; 21 Suppl():BE42-4. PubMed ID: 12874979
    [No Abstract]   [Full Text] [Related]  

  • 9. Calling for entrepreneurs: London.
    Smaglik P
    Nat Biotechnol; 2002 Dec; 20(12):1281-2. PubMed ID: 12454679
    [No Abstract]   [Full Text] [Related]  

  • 10. Do governance, equity characteristics, and venture capital nvolvement affect long-term wealth creation in U.S. health care and biotechnology IPOs?
    Williams DR; Duncan WJ; Ginter PM; Shewchuk RM
    J Health Care Finance; 2006; 33(1):54-71. PubMed ID: 21110493
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Commercializing biotechnology in the UK.
    Searle S; Graves B; Towler C
    Nat Biotechnol; 2003 Jul; 21 Suppl():BE33-5. PubMed ID: 12874976
    [No Abstract]   [Full Text] [Related]  

  • 12. Biologist aims to ease the pain for entrepreneurs.
    Gewin V
    Nature; 2006 Apr; 440(7085):738-9. PubMed ID: 16598227
    [No Abstract]   [Full Text] [Related]  

  • 13. Who took the tech out of biotech?
    Silverman E
    Nat Biotechnol; 2006 Mar; 24(3):255-6. PubMed ID: 16525373
    [No Abstract]   [Full Text] [Related]  

  • 14. Japanese firms broaden investment focus to early biotech.
    Louët S; Sipp D
    Nat Biotechnol; 2004 Aug; 22(8):931-2. PubMed ID: 15286631
    [No Abstract]   [Full Text] [Related]  

  • 15. Enthusiasm cools in Q2.
    Lawrence S
    Nat Biotechnol; 2005 Aug; 23(8):914. PubMed ID: 16082352
    [No Abstract]   [Full Text] [Related]  

  • 16. The entrepreneur and the business plan.
    Shirey MR
    Clin Nurse Spec; 2007; 21(3):142-4. PubMed ID: 17495548
    [No Abstract]   [Full Text] [Related]  

  • 17. Private company profiles.
    Nat Biotechnol; 2003 Jul; 21 Suppl():BE23-8. PubMed ID: 12874973
    [No Abstract]   [Full Text] [Related]  

  • 18. Giving your spinout the right spin.
    McElroy D
    Nat Biotechnol; 2003 Jul; 21 Suppl():BE39-41. PubMed ID: 12874978
    [No Abstract]   [Full Text] [Related]  

  • 19. The habits of successful bioentrepreneurs.
    Hodgson J; Ward M
    Nat Biotechnol; 2003 Jul; 21 Suppl():BE3-5. PubMed ID: 12874969
    [No Abstract]   [Full Text] [Related]  

  • 20. Technology transfer and idea commercialization.
    Sheft J
    Nat Biotechnol; 2008 Jun; 26(6):711-2. PubMed ID: 18536695
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.